ZOCCALI, CARMINE
 Distribuzione geografica
Continente #
AS - Asia 10.223
NA - Nord America 3.756
EU - Europa 2.356
SA - Sud America 1.994
AF - Africa 169
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 1
Totale 18.518
Nazione #
SG - Singapore 4.726
US - Stati Uniti d'America 3.495
CN - Cina 1.935
BR - Brasile 1.635
VN - Vietnam 1.098
HK - Hong Kong 1.095
RU - Federazione Russa 689
FR - Francia 645
IT - Italia 453
KR - Corea 344
BD - Bangladesh 245
JP - Giappone 171
IN - India 159
AR - Argentina 125
CA - Canada 109
DE - Germania 101
GB - Regno Unito 95
NL - Olanda 88
MX - Messico 67
ID - Indonesia 60
FI - Finlandia 59
EC - Ecuador 55
IL - Israele 51
IQ - Iraq 49
CO - Colombia 47
ZA - Sudafrica 46
SA - Arabia Saudita 45
TR - Turchia 36
UA - Ucraina 35
PY - Paraguay 31
MA - Marocco 30
ES - Italia 29
PK - Pakistan 29
PL - Polonia 29
VE - Venezuela 29
PE - Perù 23
UZ - Uzbekistan 22
CL - Cile 21
UY - Uruguay 21
JM - Giamaica 20
MY - Malesia 20
EG - Egitto 17
NP - Nepal 17
AU - Australia 16
DZ - Algeria 16
TH - Thailandia 16
TT - Trinidad e Tobago 16
JO - Giordania 15
SE - Svezia 14
PH - Filippine 13
TN - Tunisia 13
AZ - Azerbaigian 12
IE - Irlanda 12
KE - Kenya 12
AE - Emirati Arabi Uniti 10
AL - Albania 10
TW - Taiwan 10
CR - Costa Rica 9
HN - Honduras 9
LT - Lituania 9
AT - Austria 8
HR - Croazia 8
KZ - Kazakistan 8
RS - Serbia 8
AO - Angola 7
BG - Bulgaria 7
KG - Kirghizistan 7
NI - Nicaragua 7
BO - Bolivia 6
CZ - Repubblica Ceca 6
LB - Libano 6
RO - Romania 6
BE - Belgio 5
GT - Guatemala 5
HU - Ungheria 5
OM - Oman 5
PA - Panama 5
CH - Svizzera 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
LV - Lettonia 4
PT - Portogallo 4
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
EE - Estonia 3
GR - Grecia 3
LK - Sri Lanka 3
MD - Moldavia 3
NG - Nigeria 3
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
GE - Georgia 2
IM - Isola di Man 2
KW - Kuwait 2
MN - Mongolia 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
Totale 18.481
Città #
Singapore 2.810
Hong Kong 1.085
Santa Clara 793
Hefei 768
Lauterbourg 576
San Jose 440
Ho Chi Minh City 386
Seoul 340
Ashburn 308
Beijing 274
Hanoi 254
Los Angeles 146
New York 137
Tokyo 113
São Paulo 111
Dallas 100
Buffalo 61
Rio de Janeiro 60
Da Nang 54
Minamishinagawa 48
Milan 45
Frankfurt am Main 44
Haiphong 43
Rome 41
Helsinki 38
Toronto 36
Belo Horizonte 32
Curitiba 32
Brasília 28
Orem 28
Bengaluru 27
Thái Bình 26
Chicago 25
Naples 25
Salvador 25
Brooklyn 24
Guayaquil 24
Biên Hòa 22
Campinas 20
Hải Dương 20
Shanghai 20
Warsaw 20
Baghdad 19
Porto Alegre 19
Tashkent 19
Lappeenranta 18
Dhaka 17
Houston 17
Quito 17
Amsterdam 16
Elk Grove Village 16
Guangzhou 16
Johannesburg 16
Manaus 16
Montreal 16
Shenzhen 16
Atlanta 15
Council Bluffs 15
Lima 15
Montevideo 15
Phoenix 15
The Bronx 15
Amman 14
Bắc Ninh 14
Riyadh 14
Bogotá 13
Cape Town 13
Guarulhos 13
Istanbul 13
Juiz de Fora 13
New Delhi 13
São Bernardo do Campo 13
Thái Nguyên 13
Bangkok 12
Bologna 12
Chennai 12
Dammam 12
Fortaleza 12
Nuremberg 12
Sorocaba 12
Vitória da Conquista 12
Wuhan 12
Asunción 11
Baku 11
Belém 11
Catania 11
Jeddah 11
Joinville 11
Newark 11
Ninh Bình 11
Bắc Giang 10
Delhi 10
Denver 10
Goiânia 10
Ha Long 10
Hangzhou 10
Kuala Lumpur 10
London 10
Miami 10
Mumbai 10
Totale 10.279
Nome #
Il rapporto vita fianchi predice la mortalità nei pazienti in dialisi in maniera opposta rispetto all'indice di massa corporea. 687
Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study 105
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update 91
Can the assessment of ultrasound lung water in haemodialysis patients be simplified? 91
I test diagnostici e l'analisi della curva ROC. 87
Socioeconomic Status and Clinical Outcomes in Chronic Kidney Disease: Bootstrap Validation of a Simple Indicator 87
Epidemiology of hyperkalemia in CKD patients under nephrological care: a longitudinal study 86
Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study 84
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? 81
Long-term blood pressure monitoring by office and 24-h ambulatory blood pressure in renal transplant patients: a longitudinal study 73
Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients 73
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 73
Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis 72
Major adipose tissue Cytokines Leptin and Adiponectin interact with central obesity in explaining the variability in all-cause and cardiovascular death in a high risk population. 71
Be careful with ecological associations 71
Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients 68
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis 67
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies 66
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study 66
Blood Pressure (Bp) Control And Left Ventricular Hypertrophy (Lvh) In Chronic Renal Insufficiency (Cri): The Italian Multicentre Survey. 65
Serum gamma-glutamyltransferase, oxidized LDL and mortality in the elderly 64
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area 64
Patterns of pharmacologic treatment of hypertension in CKD patients stage 3-5: data from the SIR-SIN Study. 63
Asymmetric and Symmetric Dimethylarginine and Sympathetic Nerve Traffic after Renal Denervation in Patients with Resistant Hypertension 63
Sleep-Disordered Breathing and 24-Hour Ambulatory Blood Pressure Monitoring in Renal Transplant Patients: Longitudinal Study 63
Pulse Wave Velocity and Prognosis in End-Stage Kidney Disease 62
Nocturnal Hypertension and Altered Night-Day BP Profile and Atherosclerosis in Renal Transplant Patients 61
Modalità di stima del filtrato glomerulare (FG) e inizio della dialisi. Dati preliminari dello studio SIR-SIN della Società Italiana di Nefrologia nella popolazione affetta da IRC in terapia conservativa. 60
Reporting of interaction. 60
Phosphate and the renoprotective effect of ace inhibition: a post-hoc analysis of the Rein Trial. 60
Sindrome metabolico y aspectos epidemiologicos de la enfermedad renal cronica. 60
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 60
Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients 60
The dominant prognostic value of physical functioning among quality of life domains in end-stage kidney disease 60
An introduction to joint models—applications in nephrology 59
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study 59
Haemoglobin and endothelium-dependent vasodilation in uncomplicated, untreated subjects with essential hypertension. 58
Hypertension in kidney transplantation: a consensus statement of the ‘hypertension and the kidney’ working group of the European Society of Hypertension 58
The bidirectional link between left ventricular hypertrophy and chronic kidney disease. A cross lagged analysis 58
The sirtuinl gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study 57
Long-Term Changes in Sleep Disordered Breathing in Renal Transplant Patients: Relevance of the BMI 57
Renal artery stenosis is an independent predictor of left ventricular hypertrophy. 56
CAN THE ASSESSMENT OF ULTRASOUND LUNG WATER IN HEMODIALYSIS PATIENTS BE SIMPLIFIED? 56
Conducting correlation analysis: important limitations and pitfalls 56
Creatinine calibration and CKD staging 55
Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: a secondary analysis of the EXCITE trial 55
Matching, an appealing method to avoid confounding? 54
Le misure di frequenza negli studi epidemiologici: l incidenza e la prevalenza. 54
La necessità di estendere la nefrologia al territorio. 53
Sleep Disordered Breathing in Renal Transplant Patients. 53
Adiponectin and Leptin in chronic kidney disease: causal factors or mere risk markers? 52
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD 52
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 51
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure 51
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study 51
Waist circumference but not Body Mass Index (BMI) reflects the inflammation in dialysis patients. 50
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 50
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage 50
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 50
Intact FGF23 and ?-klotho during acute inflammation/sepsis in CKD patients 49
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study 48
FGF23 and the PTH response to paricalcitol in chronic kidney disease 48
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 48
Prognostic values of left ventricular mass index in chronic kidney disease patients 48
Chronic kidney disease certification process manual by the Italian Society of Nephrology (SIN): part II: programme management and clinical information management. 47
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 47
Renal safety of catheter-based renal denervation: systematic review and meta-analysis 47
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 47
Sample size calculations: basic principles and common pitfalls. 46
Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. 46
Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review 46
Biomarkers of CVD risk in CKD 45
Points of attention when conducting etiological research 45
Detection of pulmonary congestion by chest ultrasound (US) in dialysis patients. 44
The burden of progressive renal function loss, with special intention to European situation. 44
Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial 44
When impact trials are not feasible: alternatives to study the impact of prediction models on clinical practice 44
Mendelian randomization: a new approach to studying epidemiology in ESRD 44
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. 43
Circulating E-selectin as a risk marker in patients with end-stage renal disease 43
Effects: Causal effects. 43
Differences between GFR estimation by an equation based on creatinine and one based on Cystatine C 43
Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients 43
Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value ventricular hypertrophy progression. 43
Resistin and all-cause and cardiovascular mortality: Effect modification by adiponectin in end-stage kidney disease patients 43
Neuropeptide Y and chronic kidney disease progression: a cohort study 43
Insulin resistance in chronic kidney disease: a systematic review 43
Obesity and the epidemiology and prevention of kidney disease: waist circumference versus body mass index. 42
Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end stage renal disease. 42
Stabilità cardiovascolare nelle terapie convettive. 41
Valore prognostico della disfunzione sistolica asintomatica nei pazienti in dialisi. 41
Stenting of renal artery stenosis in coronary artery disease (RAS-CAD) study: a prospective, randomized TRIAL. 40
eNOS and Caveolin-1 Gene Polymorphisms Interaction and Intima Media Thickness: A Proof of Concept Study in ESRD Patients. 40
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 40
The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: Evidence for interaction with obesity in diabetic patients 40
Interaction between abdominal obesity and dyslipidemia in the prediction of overall and cardiovascular mortality in ESRD. 39
Abdominal obesity modifies the risk of hypertriglyceridemia for a all-cause and cardiovascular mortality in hemodialysis patients 39
Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients. 39
Effectiveness of cold HD for the prevention of HD hypotension and mortality in the general HD population 39
Semeiotica della pressione arteriosa 39
Totale 6.164
Categoria #
all - tutte 68.039
article - articoli 37.500
book - libri 86
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.031
Totale 106.656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202495 0 0 0 0 0 0 0 0 47 9 37 2
2024/20256.406 40 48 577 419 816 45 100 198 124 123 2.085 1.831
2025/202611.776 531 907 1.149 1.731 1.891 295 1.861 847 1.310 600 384 270
2026/2027464 464 0 0 0 0 0 0 0 0 0 0 0
Totale 18.741